Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Biota Pharmaceuticals Inc    NABI   US6295191091

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Biota Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of products to prevent and treat serious and potentially life-threatening infectious diseases.The Company currently has two Phase 2 clinical-stage product candidates in development: laninamivir... 
Sector
Biotechnology & Medical Research
Calendar
03/10 | 10:00amPresentation
More about the company
Financials ($)
Sales 2015 26,0 M
EBIT 2015 -10,7 M
Net income 2015 -
Debt 2015 -
Yield 2015 -
Sales 2016 16,9 M
EBIT 2016 -16,5 M
Net income 2016 -
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 3,45x
Capi. / Sales 2016 5,29x
Capitalization 89,5 M
More Financials
Latest news on BIOTA PHARMACEUTICALS INC
03/03 Biota Pharmaceuticals to Present at the 27th Annual Roth Conference
03/03 BIOTA PHARMACEUTICALS : Commences Dosing in Vapendavir SPIRITUS Phase 2b Trial
02/26 BIOTA PHARMACEUTICALS : Entry into a Material Definitive Agreement, Regulation F..
02/26 BIOTA PHARMACEUTICALS : to Acquire Anaconda Pharma
02/10 BIOTA PHARMACEUTICALS : Valuable Updates on Pharmaceutical Companies: New Resear..
02/06 BIOTA PHARMACEUTICALS : Reports Second Quarter Fiscal Year 2015 Financial Result..
02/06 BIOTA PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condit..
02/06 BIOTA PHARMACEUTICALS : Results of Operations and Financial Condition, Financial..
More news
Sector news Bio Therapeutic Drugs
03/03 ALKERMES : rsquo; Corporate Presentation to be Webcast at the Barclays Global He..
03/03 ACTELION : New Drug Application for selexipag (Uptravi) is accepted by the US FD..
03/03 MEDIVATION : Tuesday 3/3 Insider Buying Report: MDVN, QSR
Plus d'actualités du secteur Bio Therapeutic Drugs
Comments 
Advertisement
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF